Click here! This acquisition will also mark the return of Nimmagadda Prasad to the pharma industry after a 17-year hiatus. Prasad has been a serial entrepreneur having developed significant businesses (Matrix Laboratorties and CARE Hospitals) to scale and creating enhanced shareholder value.
Commenting on the development, Gunupati Swathi Reddy, Executive Director, IQuest Enterprises said, "We are excited about our largest investment in the pharmaceutical sector till date. Our investment comes at an opportune time when India is drawing significant attention amongst the global pharma industry.
Read more on livemint.com